1. (a) The Department, in consultation with the Statewide Steering Committee on Sickle Cell Disease, shall establish and implement a system of providing information on the sickle cell trait or the thalassemia trait to:

   1. (1) An individual who has the sickle cell trait or the thalassemia trait, including as determined through a newborn screening under § 18-502 of this subtitle; and
   2. (2) If the individual is a minor, the individual's family.

2. (b) The Department shall include the following in the information provided under subsection (a) of this section:

   1. (1) How the sickle cell trait or the thalassemia trait impacts the health of an individual with the trait; and
   2. (2) How the sickle cell trait or the thalassemia trait is passed from a parent to a child.

Added by Acts 2022, c. 279, § 1, eff. July 1, 2022; Acts 2022, c. 280, § 1, eff. July 1, 2022.